Donald H. Chamberlain

625 total citations
9 papers, 402 citations indexed

About

Donald H. Chamberlain is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Donald H. Chamberlain has authored 9 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Obstetrics and Gynecology, 5 papers in Reproductive Medicine and 3 papers in Surgery. Recurrent topics in Donald H. Chamberlain's work include Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Uterine Myomas and Treatments (3 papers). Donald H. Chamberlain is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Uterine Myomas and Treatments (3 papers). Donald H. Chamberlain collaborates with scholars based in United States, Sweden and Italy. Donald H. Chamberlain's co-authors include Todd Tillmanns, Peter R. Johnson, Scott Kamelle, M. Patrick Lowe, Saurabh Kumar, Lars Sternås, Bengt Tholander, Serafina Mammoliti, Giorgia Mangili and Ian Quirt and has published in prestigious journals such as Journal of Clinical Oncology, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Donald H. Chamberlain

8 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald H. Chamberlain United States 8 187 161 153 101 88 9 402
Sérgio A. Triginelli Brazil 11 203 1.1× 99 0.6× 73 0.5× 127 1.3× 113 1.3× 27 351
Hidehiko Moromizato Japan 11 216 1.2× 88 0.5× 96 0.6× 149 1.5× 117 1.3× 23 352
H.W.H.M. van der Putten Netherlands 11 228 1.2× 166 1.0× 101 0.7× 61 0.6× 101 1.1× 16 406
Yusuke Matsuura Japan 12 204 1.1× 203 1.3× 55 0.4× 64 0.6× 68 0.8× 42 403
M.G. Salerno Italy 12 135 0.7× 233 1.4× 93 0.6× 147 1.5× 43 0.5× 13 334
Joan E. Woodward United States 11 230 1.2× 188 1.2× 112 0.7× 112 1.1× 72 0.8× 12 454
Nilsa C. Ramirez United States 9 243 1.3× 179 1.1× 85 0.6× 58 0.6× 74 0.8× 12 368
L. P. Bloss United States 8 116 0.6× 219 1.4× 70 0.5× 119 1.2× 38 0.4× 23 358
Ioannis Biliatis United Kingdom 13 331 1.8× 268 1.7× 84 0.5× 86 0.9× 139 1.6× 29 519
A. Maggioni Italy 8 270 1.4× 255 1.6× 88 0.6× 173 1.7× 100 1.1× 18 467

Countries citing papers authored by Donald H. Chamberlain

Since Specialization
Citations

This map shows the geographic impact of Donald H. Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald H. Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald H. Chamberlain more than expected).

Fields of papers citing papers by Donald H. Chamberlain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald H. Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald H. Chamberlain. The network helps show where Donald H. Chamberlain may publish in the future.

Co-authorship network of co-authors of Donald H. Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of Donald H. Chamberlain. A scholar is included among the top collaborators of Donald H. Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald H. Chamberlain. Donald H. Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Colombo, Nicoletta, Giorgia Mangili, Serafina Mammoliti, et al.. (2011). A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites. Gynecologic Oncology. 125(1). 42–47. 69 indexed citations
2.
Lowe, M. Patrick, Saurabh Kumar, Peter R. Johnson, et al.. (2010). Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature. Journal of Robotic Surgery. 4(2). 109–115. 18 indexed citations
3.
Lowe, M. Patrick, Peter R. Johnson, Scott Kamelle, et al.. (2009). A Multiinstitutional Experience With Robotic-Assisted Hysterectomy With Staging for Endometrial Cancer. Obstetrics and Gynecology. 114(2). 236–243. 79 indexed citations
4.
Lowe, M. Patrick, Donald H. Chamberlain, Scott Kamelle, Peter R. Johnson, & Todd Tillmanns. (2009). A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer. Gynecologic Oncology. 113(2). 191–194. 89 indexed citations
5.
Colombo, N., Giorgia Mangili, Serafina Mammoliti, et al.. (2008). Aflibercept (VEGF Trap) for advanced epithelial ovarian cancer (EOC) patients (pts) with symptomatic malignant ascites: Preliminary results of a pilot study. Journal of Clinical Oncology. 26(15_suppl). 14598–14598. 19 indexed citations
6.
Reid, Gary C., James A. Roberts, Michael P. Hopkins, et al.. (1993). Primary Treatment of Stage III Ovarian Carcinoma with Sequential Chemotherapy and Whole Abdominal Radiation Therapy. Gynecologic Oncology. 49(3). 333–338. 1 indexed citations
7.
Chamberlain, Donald H., Michael P. Hopkins, James A. Roberts, et al.. (1991). The effects of early removal of indwelling urinary catheter after radical hysterectomy. Gynecologic Oncology. 43(2). 98–102. 15 indexed citations
8.
Chamberlain, Donald H., et al.. (1988). Fallopian tube cancer.. PubMed. 38(5). 121–4. 20 indexed citations
9.
Feld, Ronald, William K. Evans, George Deboer, et al.. (1984). Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.. Journal of Clinical Oncology. 2(4). 294–304. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026